LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Forconi, F. [1 ]
Fabbri, A. [1 ]
Lenoci, M. [1 ]
Sozzi, E. [1 ]
Bocchia, M. [1 ]
Gozzetti, A. [1 ]
Tassi, M. [1 ]
Raspadori, D. [1 ]
Lauria, F. [1 ]
机构：
[1] Univ Siena, I-53100 Siena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0093
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
    Dartigeas, Caroline
    Van Den Neste, Eric
    Berthou, Christian
    Maisonneuve, Herve
    Lepretre, Stephane
    Dilhuydy, Marie-Sarah
    Bene, Marie-Christine
    Nguyen-Khac, Florence
    Letestu, Remi
    Cymbalista, Florence
    De Guibert, Sophie
    Aurran, Therese
    Laribi, Kamel
    Vilque, Jean-Pierre
    Tournilhac, Olivier
    Delmer, Alain
    Feugier, Pierre
    Cazin, Bruno
    Michallet, Anne-Sophie
    Levy, Vincent
    Troussard, Xavier
    Delepine, Roselyne
    Tavernier, Elsa
    Colombat, Philippe
    Leblond, Veronique
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 328 - 334
  • [22] Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
    Wierda, W
    O'Brien, S
    Wen, S
    Faderl, S
    Garcia-Manero, G
    Thomas, D
    Do, KA
    Cortes, J
    Koller, C
    Beran, M
    Ferrajoli, A
    Giles, F
    Lerner, S
    Albitar, M
    Kantarjian, H
    Keating, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4070 - 4078
  • [23] Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia
    Robak, Tadeusz
    Lech-Maranda, Ewa
    Robak, Pawel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1529 - 1543
  • [24] Economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia
    Felipe Casado, Luis
    Garcia Marco, Jose Antonio
    Gilsanz, Florinda
    Gonzalez, Marcos
    Rios, Eduardo
    de la Serna, Javier
    Urbano, Alvaro
    Vicente, Vicente
    Rubio-Terres, Carlos
    Castro, Antonio J.
    GACETA SANITARIA, 2011, 25 (04) : 274 - 281
  • [25] Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia
    Rossi, JF
    Van Hoof, A
    De Boeck, K
    Johnson, SA
    Bron, D
    Foussard, C
    Lister, TA
    Berthou, C
    Kramer, MHH
    Littlewood, TJ
    Marcus, RE
    Deconinck, E
    Montillo, M
    Guibon, O
    Tollerfield, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1260 - 1267
  • [26] Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study
    Leblond, Veronique
    Cantin, Guy
    Cortelezzi, Agostino
    Knauf, Wolfgang
    Tiab, Mourad
    Turgut, Mehmet
    Zaritskey, Andrey
    Merot, Jean-Louis
    Trunzer, Kerstin
    Robson, Susan
    Gresko, Ekaterina
    Stilgenbauer, Stephan
    Foa, Robin
    Bosch, Francesc
    BLOOD, 2017, 130
  • [27] Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia
    Gozzetti, Alessandro
    Candi, Veronica
    Fabbri, Alberto
    Schiattone, Luana
    Cencini, Emanuele
    Lauria, Francesco
    Frasconi, Adele
    Crupi, Rosaria
    Raspadori, Donatella
    Papini, Giulia
    Defina, Marzia
    Bartalucci, Giulia
    Bocchia, Monica
    LEUKEMIA RESEARCH, 2014, 38 (08) : 891 - 895
  • [28] Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia
    Laurenti, Luca
    Piccioni, Paola
    Tarnani, Michela
    De Padua, Laura
    Garzia, Mariagrazia
    Efremov, Dimiter G.
    Piccirillo, Nicola
    Chiusolo, Patrizia
    Sica, Simona
    Leone, Giuseppe
    LEUKEMIA RESEARCH, 2007, 31 (02) : 253 - 256
  • [29] Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As Inital Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia
    Zhu, Huayuan
    Sha, Yeqin
    Miao, Yi
    Qin, Shuchao
    Shen, Hui
    Qiu, Jingyan
    Wu, Wei
    Xia, Yi
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2022, 140 : 4164 - 4165
  • [30] Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia
    Castagna, L
    Sarina, B
    Santoro, A
    BLOOD, 2003, 102 (06) : 2309 - 2309
12345